Dear investors, analysts and media:
UTime Ltd (“UTtime”) has recently experienced unusual price volatility in the capital markets As a responsible company, we understand the concerns of market participants about these conditions and we believe that it is necessary to provide clear and formal to the public. information to provide care in this regard.
First, the Company’s Board of Directors and management are very concerned about the unusual change in the share price recently. We work closely with relevant authorities to ensure that all disclosures comply with regulatory requirements and protect the interests of investors. Currently, the company is operating normally and no event has occurred that affects the company’s fundamentals. And we recently announced that we have officially entered the medical industry with the renowned physician Dr. Ehud Baron and relevant research groups plan to acquire a laboratory focused on the development of a monkeypox vaccine.
Secondly, we have seen several speculations and rumors about the company in the market and we would like to clearly point out that you should not believe unconfirmed news unless it is published through official channels. The company remains committed to creating value for shareholders and maintaining sustainable business growth.
In response to these price fluctuations, the Company has initiated an internal investigation to determine whether there is a leak of undisclosed information or other factors that could affect the stock price and, if so necessary, they may retain attorneys to initiate short sale investigation actions. At the same time, we will strengthen communication with investors to ensure the fairness and transparency of the market.
Finally, the company asks all investors to remain rational and not be influenced by short-term emotions in the market. We promise to notify you immediately of any progress or new information through official channels.
Thank you for your understanding and support. The company will continue to monitor the situation and provide updated information as appropriate. Please wait for our official notification.
There is information about the company UTime Limited
Founded in 2008, UTime Limited provides affordable mobile devices to consumers around the world and helps low-income people in established markets such as the United States and emerging markets such as India and countries in South Asia and Africa to gain greater access to the latest mobile technology. Since 2024, UTime has been committed to advancing health and wellness through innovative medical wearable technologies. By leveraging cutting-edge research and strategic partnerships, UTime aims to provide effective solutions for disease prevention and health management on a global scale. For more information, visit the company’s website at http://www.utimeworld.com/.
Forward looking statements
Statements in this press release regarding future expectations, plans and expectations, and any other statements on matters that are not historical facts, may constitute “forward-looking statements” within the meaning of Section 21E of Securities Exchange Act of 1934, as amended, and the US Private Securities Exchange Act Litigation Reform Act of 1995 The words “expect,” “believe,” “continue,” “could,” “estimate, ” “expect,” “intend,” “may,” “plan,” “potential,” “predict,” “project,” “should,” “target,” “will,” “would” and similar expressions are intended to indicate forward-looking statements, although not all such statements are forward-looking. Actual results may differ due to a number of important factors The “Risk Factors” section of the Company’s Annual Report on Form 20-F filed with the Securities and Exchange Commission on July 30, 2024 may be to quite different from those described in such a forward view. statements. Any forward-looking statements in this press release speak only as of the date hereof and the Company specifically disclaims any obligation to update any forward-looking statements, whether as a result on new information, future events or otherwise.
For more information contact: Eaky Tan
View original content:https://www.prnewswire.com/news-releases/bemerkenswerte-ankundigung-zu-den-signifikanten-schwankungen-des-utime-aktienkurses-302234644.html
